Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?

References

• Shannon J, Blythe S, Peters K. The complexities associated with caring for hospitalised infants with neonatal abstinence syndrome: the perspectives of nurses and midwives. Children. 2021;8(2):152.
   PubMedGoogle Scholar
• Barry JM, Birnbaum AK, Jasin LR, et al. Maternal exposure and neonatal effects of drugs of abuse. J Clin Pharmacol. 2021;61(S2):S142–S155.
   PubMedGoogle Scholar
• McQueen K, Murphy-Oikonen J. Neonatal abstinence syndrome. Longo DL, ed. N Engl J Med. 2016;375(25):2468–2479.
   PubMed Web of Science ®Google Scholar
• Wexelblatt SL, Ward LP, Torok K, et al. Universal maternal drug testing in a high-prevalence region of prescription opiate abuse. J Pediatr. 2015;166(3):582–586.
   PubMed Web of Science ®Google Scholar
• Hall ES, Wexelblatt SL, Crowley M, et al. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics. 2014;134(2):e527–e534.
   PubMed Web of Science ®Google Scholar
• Patrick SW, Barfield WD, Poindexter BB, et al. Neonatal opioid withdrawal syndrome. Pediatrics. 2020;146(5):e2020029074.
   PubMed Web of Science ®Google Scholar
• Goodman DJ, Wolff KB. Screening for substance abuse in women’s health: a public health imperative. J Midwifery Womens Health. 2013;58(3):278–287.
   PubMed Web of Science ®Google Scholar
• Hirai AH, Ko JY, Owens PL, et al. Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017. JAMA. 2021;325(2):146.
   PubMed Web of Science ®Google Scholar
• Patrick SW, Schiff DM, Ryan SA, et al. A public health response to opioid use in pregnancy. Pediatrics. 2017;139(3):e20164070.
   PubMed Web of Science ®Google Scholar
• Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy. Obstetrics and Gynecology. 2017;130(2):e81–e94.
   PubMed Web of Science ®Google Scholar
• Berra A, Kamo S, Mohnot S, et al. The association between antenatal maternal self-reported substance use, maternal characteristics, and obstetrical variables. J Addict Med. 2019;13(6):464–469.
   PubMed Web of Science ®Google Scholar
• Bell SG. Drug screening in neonates. Neonatal Netw. 2016;35(5):321–326.
   PubMedGoogle Scholar
• Hadland SE, Levy S. Objective testing: urine and other drug tests. Child Adolesc Psychiatr Clin N Am. 2016;25(3):549–565.
   PubMed Web of Science ®Google Scholar
• Yossuck P, Tacker DH. Drug positivity findings from a universal umbilical cord tissue drug analysis program in appalachia. J Appl Lab Med. 2021;6(1):285–297.
   PubMedGoogle Scholar
• Colby JM, Adams BC, Morad A, et al. Umbilical cord tissue and meconium may not be equivalent for confirming in utero substance exposure. J Pediatr. 2019;205:277–280.
   PubMed Web of Science ®Google Scholar
• Colby JM. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure. Clin Biochem. 2017;50(13–14):784–790.
   PubMed Web of Science ®Google Scholar
• Montgomery D, Plate C, Alder SC, et al. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. J Perinatol. 2006;26(1):11–14.
   PubMed Web of Science ®Google Scholar
• de Castro A, Jones HE, Johnson RE, et al. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. Ther Drug Monit. 2011;33(4):443–452.
   PubMed Web of Science ®Google Scholar
• de Castro A, Jones HE, Johnson RE, et al. Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. Clin Chem. 2011;57(3):449–458.
   PubMed Web of Science ®Google Scholar
• Gray TR, Choo RE, Concheiro M, et al. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome. Addiction. 2010;105(12):2151–2159.
   PubMed Web of Science ®Google Scholar
• Kacinko SL, Jones HE, Johnson RE, et al. Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. Clin Pharmacol Ther. 2008;84(5):604–612.
   PubMed Web of Science ®Google Scholar
• di Trana A, Maida N l, Tittarelli R, et al. Focus series: therapeutic drug monitoring during pregnancy and lactation monitoring prenatal exposure to buprenorphine and methadone. 2019. https://journals.lww.com/drug-monitoring.
   Google Scholar
• Gray T, Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem. 2007;388(7):1455–1465.
   PubMed Web of Science ®Google Scholar
• Wabuyele SL, Colby JM, Mcmillin GA. Detection of drug-exposed newborns. 2018. https://journals.lww.com/drug-monitoring.
   Google Scholar
• Hudak ML, Tan RC, Frattarelli DAC, et al. Neonatal drug withdrawal. Pediatrics. 2012;129(2):e540–e560.
   PubMed Web of Science ®Google Scholar
• Concheiro M, Jones HE, Johnson RE, et al. Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes. Ther Drug Monit. 2010;32(2):206–215.
   PubMed Web of Science ®Google Scholar
• Palmer KL, Wood KE, Krasowski MD. Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: a retrospective study at an academic medical center. Clin Biochem. 2017;50(6):255–261.
   PubMed Web of Science ®Google Scholar
• Patrick SW, Slaughter JC, Harrell FE, et al. Development and validation of a model to predict neonatal abstinence syndrome. J Pediatr. 2021;229:154–160.e6.
   PubMed Web of Science ®Google Scholar
• Isemann BT, Stoeckle EC, Taleghani AA, et al. Early prediction tool to identify the need for pharmacotherapy in infants at risk of neonatal abstinence syndrome. Pharmacotherapy. 2017;37(7):840–848.
   PubMed Web of Science ®Google Scholar
• Desai RJ, Huybrechts KF, Hernandez-Diaz S, et al. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015;350(may14 1):h2102–h2102.
   PubMedGoogle Scholar
• Shearer JN, Erwin PC, Davis SK, et al. Implications of Tennessee’s opioid legislation for neonatal abstinence syndrome. Policy Polit Nurs Pract. 2019;20(3):153–162.
   PubMedGoogle Scholar
• Faherty LJ, Kranz AM, Russell-Fritch J, et al. Association of punitive and reporting state policies related to substance use in pregnancy with rates of neonatal abstinence syndrome. JAMA Netw Open. 2019;2(11):e1914078.
   PubMed Web of Science ®Google Scholar